Navigation Links
Experts disagree on horses with incoordination
Date:4/10/2014

A trip to the veterinarian may prove fatal to a horse, even if it is not necessary to put the animal down. In Europe if the horse is found to be ataxic, which is most often due to the disease 'wobbler syndrome', the horse is likely to be put down immediately. If a horse suffers from this disease, putting it down can be a necessity, as the animal can be dangerous to ride and handle. But now new research from the University of Copenhagen and the Royal Veterinary College in the UK shows marked disagreement among experts about when a horse is ataxic and severity of the ataxia. It is particularly a problem if the ataxia is subtle, as this makes it more difficult to assess.

"It is a problem for both the horse and the owner if the specialists disagree. A horse which could potentially recover might be put down, as an ataxic horse eventually becomes a hazard to the owner due to the risk of a fall during riding or handling," says Emil Olsen, DVM, PhD from the Department of Large Animal Sciences, who headed up the new research.

The results were recently published in the prestigious Journal of Veterinary Internal Medicine.

No scanners for horses

Ataxia caused by Wobbler syndrome affects one in 100 horses, and is one of the greatest sources of missed training days and frustration for horse owners and veterinarians alike. The disease occurs due to pressure on the cervical spinal cord, which can be diagnosed in humans and small animals by MRI or CT scans - but there are no scanners with a diameter large enough to accommodate a horse's neck and shoulders. The foundation of the veterinarian's assessment is therefore the clinical examination of small changes and irregularities in the horse's gait.

"In this study, specialists in the areas of large animal internal medicine , specialists in equine surgery, and residents evaluated the gait during a neurological examination of 25 horses, and then videos of the horses. They completed a questionnaire, and based on their responses we could see that there was wide disagreement on whether or not they believed a horse was ataxic, and particularly on the severity of the ataxia," says Dr. Emil Olsen.

Quantifiable diagnostics

Horse owners and veterinarians often assume horses with mild ataxia are mildly lame, allowing ataxia to progress to the point of sudden falls during riding or handling. If the disease is discovered when the horse is a foal, treatment options can include restrictive feeding, and at all ages there is a surgery to stabilise the neck by fusing the cervical vertebrae. For horses with ataxia caused by articular process joint (facet joint) osteoarthritis, injecting steroids into the joint can improve the horse's condition for a period of time.

"We hope that our findings will lead to the establishment of clearer definitions for what constitutes normal and abnormal gait patterns in horses, and the relationship between spinal cord disease and ataxia. This could lead to greater agreement among specialists and practising veterinarians. The current disparity also raises the need for quantitative diagnostics, using equipment that can measure the horse's movements in detail."

If you have a horse you suspect is ataxic, please contact your veterinarian for further advice.


'/>"/>

Contact: Emil Olsen, Ph.D.
eo@sund.ku.dk
607-253-3100
University of Copenhagen
Source:Eurekalert

Related biology news :

1. The metrology experts of the future come from Braunschweig
2. More dangerous chemicals in everyday life: Now experts warn against nanosilver
3. Forensic experts compile guide on how to ID child abuse, starvation
4. International experts swarm to London for bee health summit
5. National Park Service and outside experts collaborate to conserve migratory wildlife
6. Unisys Security Experts Predict 2014 Will Be "The Year of Encryption" as Organizations Combat Growing Cyber Threats
7. CHOP and Drexel experts team up to boost pipeline of medical devices for children
8. First International Bioenergy Conference brings together world-leading experts
9. Experts from NYU Langone present new research at American College of Rheumatology 2013 Annual Meeting
10. Experts clarify conflicting criteria for diagnosing polycystic ovary syndrome
11. Marvin Test Solutions Featured at AUTOTESTCON 2013 with Leading Armament Experts and Test Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... clinical-stage oncology and dermatology biopharmaceutical company, today is ... in its previously announced rights offering of up ... common stock and Series C Convertible Preferred Stock ... As previously announced, the rights ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing and ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2017 Highlights ... increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ("China ... company in China, today announced its financial results for the ... Fourth Quarter 2016 Financial Highlights Total ... in RMB terms, or increased by 13.6% in USD terms ... of 2015. Gross profit increased by 13.3% ...
Breaking Biology Technology: